关于治疗心律失常风暴的要点
Ludovico Lazzari1, Stefano Donzelli1, Alessandra Tordini1
1SSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.
概括
节律失常风暴管理包括ICD重编程,β阻塞剂和镇静剂. 与抗心律失常药物定位相比,早期切除可能会降低死亡率和未来的冲击.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 临界护理医学 临界护理医学
背景情况:
- 失常风暴是一种危及生命的紧急情况,需要迅速,多学科的干预.
- 最初的管理重点是减少植入式心脏除器 (ICD) 冲击,上腺体阻塞和镇静.
- 抗心律失常药物通常是进一步抑制心律失常的必要条件.
研究的目的:
- 为患有心律失常风暴的患者制定管理策略.
- 根据患者风险分层,区分治疗方法.
- 为了比较早期切除与抗不律性药物定位的疗效.
主要方法:
- 审查当前的临床实践和证据,以节律失常风暴管理.
- 将患者分为低风险和高风险类别进行分层.
- 讨论药物学 (β-阻断剂,阿米奥达龙,利多卡因) 和程序干预 (ICD重编程,星状腺阻塞,全身麻醉,切除).
主要成果:
- 低风险患者可以从β抑制剂,阿米奥达龙和镇静中受益.
- 高风险患者可能需要自主调节 (恒星结阻塞) 和额外的抗失律药物 (利多卡因).
- 耐火病例可能需要全身麻醉和循环支持.
- 早期切除表明,与抗不律性定位相比,在死亡率和减震方面取得了更好的结果.
结论:
- 对节律失常风暴管理的逐步方法至关重要,根据患者的风险量身定制.
- 药理学和自主调制策略是关键的初步步骤.
- 早期导管切除提供了一个潜在的优越替代长期抗失律药物治疗,以减少死亡率和复发性冲击.
相关概念视频
01:28Disturbances in Heart Rhythm
933
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
933
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
968
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
968
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:28Mechanism of Cardiac Arrhythmias
910
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
910
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
735
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
735
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
823
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
823